Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nucl Med Biol ; 33(5): 645-51, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16843839

ABSTRACT

INTRODUCTION: (99m)Technetium stannous colloid (TcSnC) is used in white cell scanning. It labels neutrophils and monocytes via phagocytosis, with uptake mediated by the phagocytic receptor CD11b/CD18 in neutrophils. Uptake of TcSnC is altered by gram-negative infection, possibly due to the endotoxin component lipopolysaccharide (LPS) or to cytokines released during infection (e.g., TNF-alpha and IFN-gamma). Endotoxemia and increased TNF-alpha levels also occur in inflammatory bowel disease. Another potential confounder in cell labeling is that sepsis patients may be treated with GM-CSF and G-CSF, which alter phagocytic cell function. This study aimed to determine how these factors affect TcSnC cellular uptake. METHODS: Whole blood from six healthy volunteers was incubated with LPS, TNF-alpha, IFN-gamma, GM-CSF or G-CSF. Samples were then mixed with TcSnC. Blood was separated across density gradients and imaged using a gamma camera. Three radioactive count peaks were observed in each tube: free plasma activity, mononuclear cell uptake and neutrophil uptake. RESULTS: Compared with controls, significant increases in mononuclear cell uptake were induced by LPS, TNF-alpha and GM-CSF stimulation. It was incidentally noted that exogenous estrogens appear to affect TcSnC labeling and may influence the neutrophil response to stimulation. Neutrophil uptake and plasma activity were not significantly affected. IFN-gamma and G-CSF had no significant effect. CONCLUSIONS: In whole blood, the effect of LPS on TcSnC monocyte uptake is different to its effect on neutrophils, consistent with previously reported differences in CD11b/CD18 expression. TNF-alpha response parallels LPS response. GM-CSF also increases TcSnC uptake by monocytes. These effects should be considered when using TcSnC for imaging purposes, as they will tend to increase monocyte labeling. Estrogens may also affect TcSnC labeling. Responses to IFN-gamma and G-CSF are consistent with previously reported effects of these cytokines on CD11b/CD18 expression.


Subject(s)
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Lipopolysaccharides/pharmacology , Monocytes/metabolism , Neutrophils/metabolism , Technetium Compounds/blood , Technetium Compounds/pharmacokinetics , Tin Compounds/blood , Tin Compounds/pharmacokinetics , Tumor Necrosis Factor-alpha/pharmacology , Adult , Cells, Cultured , Drug Combinations , Female , Humans , Male , Middle Aged , Monocytes/drug effects , Neutrophils/drug effects , Radiopharmaceuticals/blood , Radiopharmaceuticals/pharmacokinetics
2.
Nucl Med Biol ; 33(3): 433-9, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16631093

ABSTRACT

INTRODUCTION: [(99m)Tc]-technetium stannous colloid (TcSnC)-labeled white cells are used to image inflammation. Neutrophil labeling with TcSnC is probably phagocytic, but the phagocytic receptor involved is not known. We hypothesised that complement receptor 3 (CR3) plays a key role. Phagocytic labeling could theoretically result in neutrophil activation or priming, affecting the behaviour of labeled cells. Fluorescence-activated cell sorter (FACS) analysis side scatter measurements can assess neutrophil activation and priming. METHODS: We tested whether TcSnC neutrophil labeling is CR3-mediated by assessing if neutrophil uptake of TcSnC was inhibited by a monoclonal antibody (mAb) directed at the CD11b component of CR3. We tested if TcSnC-labeled neutrophils show altered activation or priming status, comparing FACS side scatter in labeled and unlabeled neutrophils and examining the effect of lipopolysaccharide (LPS), a known priming agent. RESULTS: Anti-CD11b mAb reduced neutrophil uptake of TcSnC in a dose-dependent fashion. Labeled neutrophils did not show significantly increased side scatter compared to controls. LPS significantly increased side scatter in control cells and labeled neutrophils. However, the increase was significantly greater in labeled neutrophils than unlabeled cells. CONCLUSIONS: Neutrophil labeling with TcSnC is related to the function of CR3, a receptor which plays a central role in phagocytosis. TcSnC labeling did not significantly activate or prime neutrophils. However, labeled neutrophils showed a greater priming response to LPS. This could result in labeled neutrophils demonstrating increased adhesion on activated endothelium at sites of infection.


Subject(s)
Lipopolysaccharides/pharmacology , Neutrophils/metabolism , Radiopharmaceuticals/pharmacokinetics , Receptors, Complement 3b/metabolism , Technetium Compounds/pharmacokinetics , Tin Compounds/pharmacokinetics , CD11b Antigen/immunology , CD11b Antigen/metabolism , Cells, Cultured , Colloids , Humans , Neutrophils/drug effects
3.
Nucl Med Biol ; 32(1): 101-7, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15691667

ABSTRACT

Gram-negative infection alters phagocytic cell function; hence, it could affect phagocytic uptake of inorganic colloids by these cells. Neutrophil and monocyte uptake of technetium 99m stannous colloid (99mTc SnC) in whole blood was measured in 10 patients with gram-negative infection (Burkholderia pseudomallei) and 7 controls. Mean uptake per individual neutrophil was reduced in infection. Uptake per monocyte was not significantly different. Blood from six normal individuals was incubated with lysed B. pseudomallei and colloid, which showed reduced neutrophil uptake, but increased monocyte uptake. These results indicate that uptake of 99mTc SnC stannous colloid can be used to measure alteration in phagocytic cell function. They suggest that infection with B. pseudomallei is associated with reduced phagocytosis by individual neutrophils, possibly through toxic effects of bacterial products. This could have immunopathogenic consequences for this gram-negative infection and may explain why it responds to granulocyte colony-stimulating factor.


Subject(s)
Melioidosis/blood , Melioidosis/diagnostic imaging , Monocytes/diagnostic imaging , Monocytes/metabolism , Neutrophils/diagnostic imaging , Neutrophils/metabolism , Technetium Compounds/pharmacokinetics , Tin Compounds/pharmacokinetics , Adult , Aged , Aged, 80 and over , Burkholderia pseudomallei/growth & development , Female , Humans , Male , Melioidosis/microbiology , Middle Aged , Monocytes/microbiology , Neutrophils/microbiology , Radionuclide Imaging , Radiopharmaceuticals/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...